Resources

Selected
  • Pneumococcal disease
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

310 results found

2017 ∙ ACIP

October 2017 - meeting minutes

  • Agenda & Minutes
  • Americas
  • United States of America
  • Adolescents
  • Adults
  • vaccine safety
  • Herpes zoster
  • Influenza
  • Mumps
  • Human papillomavirus (HPV)
  • Japanese encephalitis
  • Pneumococcal disease
Download:
2017 ∙ Haute Autorité de Santé

Meeting minutes of the French NITAG - 19 December 2017

  • Agenda & Minutes
  • Europe
  • France
  • Pneumococcal disease
Download:
2017 ∙ Haute Autorité de Santé

Minutes of the CTV meeting - December 19th 2017

  • Agenda & Minutes
  • Europe
  • France
  • Pneumococcal disease
Download:
2017 ∙ Haute Autorité de Santé

Minutes of the CTV meeting - November 21st 2017

  • Agenda & Minutes
  • Europe
  • France
  • Pneumococcal disease
  • Influenza
  • Diphtheria
  • Tetanus
  • Pertussis
  • Poliomyelitis
Download:
2017 ∙ WHO AFRO

Recommendation to replace PCV-10 by PCV-13 in routine immunization of children under the age of 12

  • Recommendation
  • Africa
  • Zambia
  • Pneumococcal disease
Download:
2017 ∙ IVAC

The Evidence Base for Pneumococcal Conjugate Vaccines (PCVs)

  • Pneumococcal disease
Download:
2016 ∙ Saokaew, S. Rayanakorn, A. Wu, D. B. C. Chaiyakunapruk, N.

Cost Effectiveness of Pneumococcal Vaccination in Children in Low- and Middle-Income Countries: A Systematic Review

  • Newborn
  • Children
  • Adolescents
  • Low and Middle Income Countries
  • Pneumococcal disease
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2016 ∙ Segal, N. Greenberg, D. Dagan, R. Ben-Shimol, S.

Disparities in PCV impact between different ethnic populations cohabiting in the same region: A systematic review of the literature

  • All age groups
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Ethical issues
Methodological quality (AMSTAR 2):
Critically low
2016 ∙ Gibson, E. Begum, N. Sigmundsson, B. Sackeyfio, A. Hackett, J. Rajaram, S.

Economic evaluation of pediatric influenza immunization program compared with other pediatric immunization programs: A systematic review

  • All age groups
  • Influenza
  • Rotavirus
  • Meningococcal disease
  • Pneumococcal disease
  • Human papillomavirus (HPV)
  • Hepatitis B
  • Varicella
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2016 ∙ Remschmidt, C. Harder, T. Wichmann, O. Bogdan, C. Falkenhorst, G.

Effectiveness, immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine revaccinations in the elderly: A systematic review

  • Adults
  • Older adults
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
High
Loading...